11-beta HSD1 inhibitors (Scottish Biomedical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name11-beta HSD1 inhibitors (Scottish Biomedical)
Drug Alias Name11-beta hydroxysteroid dehydrogenase 1 inhibitors (Scottish Biomedical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSB Drug Discovery
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSB Drug Discovery
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A